Fusion Investment Group’s Gilead Sciences GILD Stock Holding History

Fusion Investment Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$531K	Buy	5,236 +201	+4%	+$20.9K	1.42%	31
2015 Q3	$494K	Buy	5,035 +2,323	+86%	+$258K	1.17%	33
2015 Q2	$318K	Buy	2,712 +1,345	+98%	+$147K	0.25%	76
2015 Q1	$134K	Buy	1,367 +1,238	+960%	+$126K	0.11%	99
2014 Q4	$12K	Sell	129 -3,450	-96%	-$357K	0.01%	102
2014 Q3	$381K	Sell	3,579 -959	-21%	-$93.9K	0.33%	46
2014 Q2	$376K	Buy	4,538 +3,502	+338%	+$273K	0.32%	53
2014 Q1	$73K	Buy	+1,036	New	+$81.3K	0.07%	112

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fusion Investment Group's GILD Position: Q4 2015 in Review

Fusion Investment Group increased its Gilead Sciences (GILD) stake by 4% in Q4 2015, buying an estimated $20.9K and bringing the position to 5,236 shares worth $531K. The position accounts for 1.42% of the portfolio, ranked #31.

Fusion Investment Group first reported a position in GILD in Q1 2014 and has held it in 8 quarters since. 1,628 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

Fusion Investment Group held 5,236 shares of Gilead Sciences worth $531K as of Q4 2015.
Fusion Investment Group bought 201 Gilead Sciences shares in Q4 2015, an estimated $20.9K.
Gilead Sciences made up 1.42% of Fusion Investment Group's portfolio in Q4 2015, its #31 holding.
Fusion Investment Group first reported a position in Gilead Sciences in Q1 2014 and has held it in 8 quarters since.
1,628 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on Fusion Investment Group's 13F filing for Q4 2015, filed 16 Feb 2016.